UM

Uma Maheshwar Kodide

Active Director Designated Partner DIN 11530253
DIN 11530253 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Uma Maheshwar Kodide

Data last updated:

Uma Maheshwar Kodide is a Designated Partner at Empyrean Hospitals Llp (since 2026) and Director at Pallidex Software Solutions Private Limited (since 2026).

DIN 11530253
Primary Designation Designated Partner
First Appointment 13 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Jul 20262026Active
Director13 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Pallidex Software Solutions Private Limited
Empyrean Hospitals Llp
Premium access

Shareholding and investment profile for Uma Maheshwar Kodide

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uma Maheshwar Kodide

Uma Maheshwar Kodide currently holds 2 directorships: Empyrean Hospitals Llp (Designated Partner, since 30 Jul 2026); Pallidex Software Solutions Private Limited (Director, since 13 Feb 2026).

Uma Maheshwar Kodide was first appointed on 13 Feb 2026 as Director at Pallidex Software Solutions Private Limited.

The current boards of Uma Maheshwar Kodide's companies include Gudimetla Vikramaditya Reddy (Empyrean Hospitals Llp), Kanthi Jayalakshmi Appannagari (Empyrean Hospitals Llp), Kumar Prasannakalyan (Pallidex Software Solutions Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available